| Literature DB >> 31838616 |
Fernanda Machado Chaves1,2, Isadora Carolina Betim Pavan1,3, Luiz Guilherme Salvino da Silva1, Lidia Broglio de Freitas3, Mauricio Ariel Rostagno1, Adriane Elisabete Costa Antunes2, Rosângela Maria Neves Bezerra1, Fernando Moreira Simabuco4,5.
Abstract
Pomegranate (Punica granatum) is known to contain polyphenols with many potential health benefits, including anti-tumoral, anti-inflammatory, and anti-microbial properties. It has been used in popular medicine for cancer treatment, which still represents the major cause of cancer-related deaths in men worldwide. Importantly, pomegranate peels are valuable by-products of the food industry that are rich in polyphenols. Here we report a comparison between juice and peel aqueous extracts in prostate cancer DU-145 and PC-3 cell lines. Both extracts were able to inhibit the proliferation, migration and colony formation of those cells, although peel extracts presented more robust effects compared to juice. Besides, the growth-related mTOR/S6K signaling pathway presented strong inhibition after pomegranate extracts treatment. This study presents evidence that both juice and isolated peel extracts from promegate fruit have important anti-cancer effects against prostate cancer cells, modulating the mTOR/S6K signaling pathway.Entities:
Keywords: Cell signaling; Ellagic acid; Peel extracts; Pomegranate; Prostate cancer; mTOR
Year: 2020 PMID: 31838616 DOI: 10.1007/s11130-019-00776-0
Source DB: PubMed Journal: Plant Foods Hum Nutr ISSN: 0921-9668 Impact factor: 3.921